malondialdehyde has been researched along with Leukemia P388 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benvenuto, JA; Farquhar, D; Hittelman, WN; Newman, RA; Pandita, TK; Plunkett, W; Zwelling, LA | 1 |
| Lin, TJ | 1 |
2 other study(ies) available for malondialdehyde and Leukemia P388
| Article | Year |
|---|---|
Biochemical pharmacology of penclomedine (NSC-338720).
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Chromatography, High Pressure Liquid; Dihydroorotate Oxidase; DNA; DNA Damage; Humans; Leukemia P388; Malondialdehyde; Picolines; Uridine | 1995 |
[Antioxidation mechanism of schizandrin and tanshinonatic acid A and their effects on the protection of cardiotoxic action of adriamycin].
Topics: Animals; Cardiovascular Agents; Cyclooctanes; Doxorubicin; Drugs, Chinese Herbal; Free Radical Scavengers; Leukemia P388; Lignans; Malondialdehyde; Mitochondria, Heart; Phenanthrenes; Polycyclic Compounds | 1991 |